Dr. Carl Landgren, MD, PhD

Dr. Carl Ola Landgren has years of experience in the fields of Hematology and Oncology. He earned his BA from Lund University and his MD and PhD from the Karolinska Institute. Formerly, this expert held roles as Chief and Attending Physician in the Myeloma Service at Memorial Sloan Kettering Cancer Center and as a Professor of Medicine at the Weill Cornell Medical College. Currently, he serves as a Co-Leader of Translational and Clinical Oncology Program, the Director of the Sylvester Myeloma Research Institute, the Chief of the Myeloma Division, a Leader of the Experimental Therapeutics Program, and the Paul J. DiMare Endowed Chair in Immunotherapy at the Sylvester Comprehensive Cancer Center. He is also a Professor in the Division of Hematology and Chief of the Myeloma Division at the University of Miami Leonard M. Miller School of Medicine, and a Physician with the University of Miami Health System.